Minneapolis VA Health Care System, Minneapolis, MN
Welcome,         Profile    Billing    Logout  
 66 Trials 
150 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bloomfield, Hanna E
NCT04309864: CMAP Refinement for Pressure Injury Prevention

Recruiting
N/A
46
US
Use of CMAP app for education (in-hospital), Use of CMAP app (in-home)
VA Office of Research and Development
Pressure Ulcer
03/25
03/25
EMPOWER, NCT05797441: Testing the Effectiveness of a Therapist-Assisted Self-Management Program for Veterans Who Finished PTSD Therapy

Enrolling by invitation
N/A
90
US
EMPOWER, Treatment As Usual
VA Office of Research and Development
PTSD, Post Traumatic Stress Disorder
03/26
03/26
Adabag, Selcuk
VA-IMPACT, NCT02915198 / 2018-000635-27: Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Recruiting
4
7410
US
Metformin XR, Placebo
VA Office of Research and Development
Prediabetic State, Atherosclerosis, Metformin
03/29
03/29
LUX-Dx TRENDS, NCT04790344: Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

Active, not recruiting
N/A
525
US
Investigational LUX-Dx ICM Implant
Boston Scientific Corporation
Heart Failure
05/26
06/26
Hagedorn, Hildi J
COMPASS, NCT04581434: Psychotherapy for PTSD Among Veterans Also Receiving Drug or Alcohol Treatment

Completed
N/A
426
US
Prolonged Exposure Therapy, Cognitive Processing Therapy, Present Centered Therapy
Center for Veterans Research and Education, Patient-Centered Outcomes Research Institute, Minneapolis Veterans Affairs Medical Center
Stress Disorders, Post-Traumatic, Substance Use Disorders
04/24
04/24
NCT06303778: Combining a Smartphone App With Medications to Manage Heavy Drinking

Not yet recruiting
N/A
330
US
Stand Down mobile app, Standard Care
VA Office of Research and Development
Alcohol Use Disorder (AUD)
09/28
09/28
Hauser, Peter
PAUSE, NCT03864146: Pioglitazone for the Treatment of Alcohol Use Disorder

Completed
N/A
201
US
Brief Behavioral Compliance Enhancement Treatment, BBCET
VA Office of Research and Development
Alcohol Use Disorder
03/24
05/24
Kinlay, Scott
VA-IMPACT, NCT02915198 / 2018-000635-27: Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Recruiting
4
7410
US
Metformin XR, Placebo
VA Office of Research and Development
Prediabetic State, Atherosclerosis, Metformin
03/29
03/29
Lim, Kelvin O
NCT02168400: Clinical Intervention in Alcohol Use Disorder

Completed
N/A
86
US
Transcranial Direct Current Stimulation (tDCS), Starstim
University of Minnesota, National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Alcohol Use Disorder, Eligible to go Into the MRI Scanner, Short-term Abstinence From Alcohol Use (2 Week Abstinent)
11/22
11/22
MINUTES, NCT03896438: Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 2

Active, not recruiting
N/A
85
US
Transcranial Direct Current Stimulation (tDCS)
University of Minnesota, National Institute of Mental Health (NIMH)
Transcranial Direct Current Stimulation, Schizophrenia, Schizoaffective Disorder
03/23
04/24
NCT03844607: Combined tDCS and Cognitive Training to Reduce Impulsivity in Patients With Traumatic Brain Injury

Active, not recruiting
N/A
33
US
Active Transcranial Direct Current Stimulation (tDCS), Sham Transcranial Direct Current Stimulation (tDCS)
Minneapolis Veterans Affairs Medical Center, Minnesota Office of Higher Education, Center for Veterans Research and Education, The Defense and Veterans Brain Injury Center
Traumatic Brain Injury, Impulsivity
03/23
01/25
NCT05589272: TDCS-potentiated Generalization of Cognitive Training in the Rehabilitation of Long COVID Symptoms

Withdrawn
N/A
60
US
Active tDCS, Sham tDCS
University of Minnesota
Post-acute Sequelae SARS-CoV-2 Infection (PASC)
09/23
09/24
NCT03773523: Neuromodulation and Cognitive Training in Opioid Use Disorder

Recruiting
N/A
30
US
Transcranial Direct Current Stimulation (tDCS), Starstim
University of Minnesota
Opioid-use Disorder, Opioid Dependence, Opioid Abuse
05/25
05/25
MINUTES, NCT03896425: Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 1

Completed
N/A
73
US
Transcranial direct current stimulation (tDCS)
University of Minnesota, National Institute of Mental Health (NIMH)
Transcranial Direct Current Stimulation, Healthy
04/24
04/24
NCT04426214: Neuromodulation and Cognitive Training for Substance Use Disorders

Recruiting
N/A
80
US
tDCS, Cognitive Training
University of Minnesota
Stimulant Use, Alcohol Use Disorder
06/24
06/24
SGB-PTSD, NCT05169190: Stellate Ganglion Block for PTSD

Recruiting
N/A
360
US
Stellate Ganglion Block, SGB or Regional Block, Sham Stellate Ganglion Block, Sham SGB
VA Office of Research and Development, Analydata, Inc
Post-traumatic Stress Disorder
12/24
03/26
NCT04574167: Effects of tDCS Paired With Cognitive Training on Brain Networks Associated With Alcohol Use Disorder in Veterans

Recruiting
N/A
120
US
Active Transcranial Direct Current Stimulation (tDCS), Sham Transcranial Direct Current Stimulation (tDCS)
VA Office of Research and Development, Minneapolis Veterans Affairs Medical Center, University of Minnesota
Alcohol Use Disorder
12/24
12/24
NCT06110715: Quantifying tACS-driven Improvement of Working Memory in Depression

Not yet recruiting
N/A
40
NA
theta tACS stimulation, sham tACS stimulation
University of Minnesota
Depression
03/27
03/27
Yoon, Gihyun
NCT04044534: Intranasal Insulin for Posttraumatic Stress Disorder

Recruiting
2
20
US
Intranasal insulin, Placebo
VA Connecticut Healthcare System
PTSD
01/25
01/25
NCT05042102: Donepezil and Cognitive Training for Alcohol Use Disorder (AUD)

Recruiting
2
160
US
Donepezil + Cognitive remediation therapy (CRT), Donepezil + Placebo CRT, Placebo medication + Cognitive remediation therapy (CRT), Placebo medication + Placebo CRT
VA Connecticut Healthcare System, Yale University, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Alcohol Use Disorder
05/26
05/26
NCT02461927: Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

Completed
1/2
65
US
Ketamine + Naltrexone, Ketamine + Placebo, Placebo (psychoactive placebo midazolam) + Placebo
VA Office of Research and Development
Major Depressive Disorder, Alcohol Use Disorder
10/23
10/23
Ishani, Areef
BRAVO, NCT05931276: CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

Recruiting
3
2540
US
Metoprolol Succinate, Carvedilol
VA Office of Research and Development
End-Stage Kidney Disease, End-Stage Renal Disease
11/25
12/27
Dieperink, Eric
PAUSE, NCT03864146: Pioglitazone for the Treatment of Alcohol Use Disorder

Completed
N/A
201
US
Brief Behavioral Compliance Enhancement Treatment, BBCET
VA Office of Research and Development
Alcohol Use Disorder
03/24
05/24
Fu, Steven S
NCT03477435: Comparing an Opt-out to an opt-in Approach for Smoking Cessation in VA Primary Care Clinics

Completed
N/A
1365
US
Staff training and academic detailing
VA Office of Research and Development
Tobacco Use
11/23
04/24
VAntagePilot, NCT04840108: Veteran Support for Smoking Cessation Pilot Project (VAntage Pilot)

Recruiting
N/A
64
US
Support Person Coaching Intervention, Support Person Written Materials
Minneapolis Veterans Affairs Medical Center
Smoking Cessation
09/24
12/24
NCT05671380: A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities

Recruiting
N/A
2000
US
Longitudinal Proactive Outreach (LPO)., Ask-Advice-Connect (AAC)
University of Minnesota
Tobacco Use Cessation, Cardiovascular Diseases, Tobacco Use, Smoking, Smoking Cessation
03/26
06/26
VAntage, NCT05868421: Veteran Social Support for Enhancing Use of Smoking Cessation Treatment

Recruiting
N/A
2376
US
Support Person Coaching Call, SP Coaching Call Intervention, SP written materials, Written support person strategies, Written Smoking Cessation Materials
VA Office of Research and Development
Smoking Cessation, Veterans Health
02/27
02/28
Miller, Joshua
NCT00619528: HLA-Identical Sibling Renal Transplant Tolerance

Active, not recruiting
N/A
230
US
Infusion of Donor Hematopoietic Stem Cells and Campath-1H
Northwestern University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Immunosuppression, Kidney Transplantation, Graft Rejection
07/22
06/23
PePS, NCT04979429: The Perioperative Pain Self-Management Program Trial

Recruiting
N/A
400
US
Perioperative Pain Self-management (PePS), PePS
VA Office of Research and Development
Postoperative Pain
07/25
07/25
Nienow, Tasha M
NCT02849223: Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury

Active, not recruiting
2
41
US
Anodal Transcranial Direct Current Stimulation, Sham stimulation
Minneapolis Veterans Affairs Medical Center, State of Minnesota, Minnesota Veterans Medical Research and Education Foundation
Traumatic Brain Injury
09/24
09/24
NCT02663349: Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness

Completed
N/A
22
US
Social Cognition and Intervention Training
Minneapolis Veterans Affairs Medical Center, Minnesota Veterans Medical Research and Education Foundation
Schizophrenia, Bipolar Disorder, Psychotic Disorders
10/18
07/19
NCT06230887: Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study

Not yet recruiting
N/A
200
US
Building Spiritual Strength, Present Centered Group Therapy
VA Office of Research and Development, VA Central Alabama Health Care System, VA Atlanta Healthcare System, Michael E. DeBakey VA Medical Center, Minneapolis Veterans Affairs Medical Center
Moral Injury Syndrome
07/27
01/28
NCT05491538: Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness

Recruiting
N/A
20
US
Social Cognition and Interaction Training-Work Edition (SCIT-WE)
VA Office of Research and Development
Schizophrenia, Bipolar Disorder, Depressive Disorder, Major, Stress Disorder, Post-Traumatic
11/24
11/24
Leehey, David J
NCT03625648: Pentoxifylline in Diabetic Kidney Disease

Recruiting
4
2510
US
Pentoxifylline, Placebo
VA Office of Research and Development
Diabetic Kidney Disease
01/28
07/30
Risk, Michael
NCT04943380: Efficacy and Utility of Cxbladder Tests in Hematuria Patients

Active, not recruiting
N/A
684
US
Cxbladder
Pacific Edge Limited
Hematuria, Urothelial Carcinoma
01/24
12/25
Burgess, Diana J
PePS, NCT04979429: The Perioperative Pain Self-Management Program Trial

Recruiting
N/A
400
US
Perioperative Pain Self-management (PePS), PePS
VA Office of Research and Development
Postoperative Pain
07/25
07/25
Drekonja, Dimitri M
MATCH, NCT03005379 / 2014-004393-41: Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home

Terminated
2/3
153
US
Fecal Microbiota Therapy (FMT), Placebo
VA Office of Research and Development
Clostridium Difficile Infection
08/22
01/23
Miller, Katherine E
NRG-GY019, NCT04095364: Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recruiting
3
450
Europe, Canada, US, RoW
Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Imaging Technique, Diagnostic Imaging Technique, Image Type, Imaging, Imaging (procedure), imaging procedure, Imaging Procedures, imaging type, IMAGING_METHOD, imaging_type, Medical Imaging, Type of imaging, Letrozole, CGS 20267, Femara, Fempro, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat
NRG Oncology, National Cancer Institute (NCI)
Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8, Stage III Fallopian Tube Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Primary Peritoneal Cancer AJCC v8, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8
02/27
02/28
NCT05432791: Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working

Suspended
2/3
190
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Scan, Bone Scintigraphy, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Olaparib, AZD 2281, AZD-2281, AZD2281, KU-0059436, Lynparza, Olanib, Olaparix, PARP Inhibitor AZD2281, Pazopanib, GW786034, Temozolomide, CCRG-81045, Gliotem, Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-, M & B 39831, M and B 39831, Methazolastone, RP-46161, SCH 52365, Temcad, Temizole, Temodal, Temodar, Temomedac, TMZ, Trabectedin, Ecteinascidin, Ecteinascidin 743, ET-743, Yondelis, Transthoracic Echocardiography, TTE
National Cancer Institute (NCI)
Locally Advanced Uterine Corpus Leiomyosarcoma, Metastatic Uterine Corpus Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8, Unresectable Uterine Corpus Leiomyosarcoma
03/30
03/30
NRG-GY029, NCT05295589: Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy

Withdrawn
2
96
US
Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Copanlisib Hydrochloride, 5-Pyrimidinecarboxamide, 2-Amino-N-(2,3-dihydro-7-methoxy-8-(3-(4-morpholinyl)propoxy)imidazo(1,2-C)quinazolin-5-yl)-, Hydrochloride (1:2), Aliqopa, BAY 80-6946 Dihydrochloride, BAY-80-6946 Dihydrochloride, Copanlisib Dihydrochloride, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, Olaparib, AZD 2281, AZD-2281, AZD2281, KU-0059436, Lynparza, PARP Inhibitor AZD2281, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Pegylated Liposomal Doxorubicin Hydrochloride, ATI-0918, Caelyx, Dox-SL, Doxil, Doxilen, Doxorubicin HCl Liposomal, Doxorubicin HCl Liposome, Doxorubicin Hydrochloride Liposome, Duomeisu, Evacet, LipoDox, Lipodox 50, Liposomal Adriamycin, Liposomal Doxorubicin Hydrochloride, Liposomal-Encapsulated Doxorubicin, Pegylated Doxorubicin HCl Liposome, S-Liposomal Doxorubicin, Stealth Liposomal Doxorubicin, TLC D-99, Topotecan Hydrochloride, Hycamptamine, Hycamtin, SKF S-104864-A, Topotecan HCl, topotecan hydrochloride (oral)
National Cancer Institute (NCI), NRG Oncology
Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Fallopian Tube High Grade Serous Adenocarcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma, Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Resistant Fallopian Tube Carcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma, Recurrent Platinum-Resistant Primary Peritoneal Carcinoma, Recurrent Primary Peritoneal Endometrioid Adenocarcinoma, Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma
03/23
03/23
ELU-FRα-1, NCT05001282: A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Active, not recruiting
1/2
79
US
ELU001, FA-CDC
Elucida Oncology
Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma, Endometrial Cancer, Ovary Cancer, Ovary Neoplasm, Ovary Disease, Ovary Metastasis, Ovarian Diseases, Ovarian Cancer Stage, Ovarian Epithelial Cancer, Ovarian Adenocarcinoma, Ovarian Serous Adenocarcinoma, Ovarian Neoplasm Epithelial, Ovarian Cancer Recurrent, Endometrial Diseases, Endometrial Adenocarcinoma, Endometrial Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrioid Adenocarcinoma, Endometrial Neoplasms, Endometrial Cancer Recurrent, Endometrioid Tumor, Fallopian Tube Cancer, Peritoneal Cancer
06/24
09/24
NCT03974503: Understanding Trauma Nightmares Using In-Home Measurement

Recruiting
N/A
80
US
Exposure, Relaxation, and Rescripting Therapy, ERRT, Sleep and Nightmare Management
VA Office of Research and Development
Nightmares, Stress Disorders, Post-Traumatic, Actigraphy, Respiratory Sinus Arrhythmia, Veterans
06/24
07/24
SOROCk, NCT04251052: A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Recruiting
N/A
2262
US, RoW
Bilateral Salpingectomy, Bilateral Salpingectomy with Oophorectomy, bilateral salpingo-oophorectomy, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Transvaginal Ultrasound, transvaginal sonography, TVS, TVU
NRG Oncology, National Cancer Institute (NCI)
Ovarian Carcinoma
06/36
06/37
Shiroma, Paulo R
VAST-D II, NCT05554627: VA Aripiprazole vs Esketamine for Treatment Resistant Depression

Withdrawn
4
940
US
Esketamine, Spravato (for depression), Ketanest (for anesthesia), Aripiprazole, Abilify, Aristada
VA Office of Research and Development
Depressive Disorder, Major
10/23
10/23
NCT06228391: Ketamine Treatment for PTSD and MDD in TBI

Not yet recruiting
2
40
US
IV ketamine, Midazolam
Minneapolis Veterans Affairs Medical Center
PTSD, Post Traumatic Stress Disorder, Major Depressive Disorder, Traumatic Brain Injury
12/26
03/27
NCT04560660: Ketamine-enhanced Prolonged Exposure Therapy in PTSD

Recruiting
2
100
US
Ketamine, Midazolam
VA Office of Research and Development
PTSD
12/24
10/25
Harris, Jeanette I
NCT06230887: Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study

Not yet recruiting
N/A
200
US
Building Spiritual Strength, Present Centered Group Therapy
VA Office of Research and Development, VA Central Alabama Health Care System, VA Atlanta Healthcare System, Michael E. DeBakey VA Medical Center, Minneapolis Veterans Affairs Medical Center
Moral Injury Syndrome
07/27
01/28
Shaukat, Aasma
MATCH, NCT03005379 / 2014-004393-41: Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home

Terminated
2/3
153
US
Fecal Microbiota Therapy (FMT), Placebo
VA Office of Research and Development
Clostridium Difficile Infection
08/22
01/23
NCT04149184: Computer-aided Detection Device in Standard Colonoscopy

Recruiting
N/A
1000
US
AI Colonoscopy Device
University of Minnesota
Colonic Polyp, Colon Cancer, Colorectal Cancer, Colorectal Polyp
12/20
12/20
PREEMPT CRC, NCT04369053: Prevention of Colorectal Cancer Through Multiomics Blood Testing

Active, not recruiting
N/A
50000
US, RoW
Freenome test, Single Group Assignment
Freenome Holdings Inc.
Colon Cancer, Rectal Cancer, Colon Neoplasm, Colon Diseases, Colon Lesion, Colon Polyp, Colorectal Cancer, Polyp, Adenoma, Rectal Diseases, Gastrointestinal Tract Cancers
05/24
05/24
NCT05585879: Demonstrating Effective Salvage of Inadequate Colonoscopies

Terminated
N/A
16
US
Pure-Vu EVS
Motus GI Medical Technologies Ltd
Colorectal Screening
04/24
04/24
NCT05646355: Flatbush FHC Proactive Colorectal Cancer Screening and Navigation

Completed
N/A
100
US
Proactive CRC Screening Outreach, Usual Care
NYU Langone Health, National Cancer Institute (NCI)
Colorectal Cancer
12/23
12/23
PROOF, NCT06269744: Proactive Outreach With FIT

Enrolling by invitation
N/A
3000
US
Proactive Screening Outreach
NYU Langone Health
Colorectal Cancer
07/25
04/26
NCT00843375: Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Recruiting
N/A
1200
Canada, US, RoW
University of Michigan Rogel Cancer Center, Early Detection Research Network, Clinical Genomics Pathology, VolitionRx, Department of Health and Human Services, Great Lakes New England Clinical Validation Center, National Cancer Institute (NCI)
Colonic Neoplasms
03/28
03/28
Ihnat, Daniel
TOP, NCT03229941: Transfusion Trigger After Operations in High Cardiac Risk Patients

Completed
N/A
3012
US
Blood Transfusion
VA Office of Research and Development
Myocardial Infarction, Coronary Revascularization, Acute Renal Failure
06/23
03/24
Garcia, Santiago
HALT, NCT04552275: The Biomarker Study

Recruiting
1
300
US
Proteomics Analysis
Massachusetts General Hospital, Medtronic, Catholic Medical Center, Minneapolis Heart Institute
Aortic Stenosis, Hypo-attenuated Leaflet Thickening, Bioprosthetic Valve Degeneration
06/30
06/35
NCT02661451: Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)

Active, not recruiting
N/A
178
Europe, Canada, US
SAPIEN 3 THV, Optimal Heart Failure Therapy
Cardiovascular Research Foundation, New York, Cardialysis BV, Avania
Aortic Valve Stenosis
02/23
02/25
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
01/25
04/30
PROGRESS CTO, NCT02061436: Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

Recruiting
N/A
2000
Europe, Canada, US, RoW
Minneapolis Heart Institute Foundation
Coronary Artery Disease
01/24
01/24
JVTF EFS, NCT06034028: J-Valve TF Early Feasibility Study

Recruiting
N/A
25
US
J-Valve TF System
JC Medical, Inc.
Aortic Valve Disease, Aortic Valve Insufficiency, Aortic Regurgitation
03/24
06/29
NCT03735667: ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

Recruiting
N/A
2820
Canada, US
ACURATE neo2â„¢ Transfemoral TAVR System, Medtronic CoreValve TAVR System, Edwards SAPIEN 3 TAVR System, ACURATE Primeâ„¢ Transfemoral TAVR System XL
Boston Scientific Corporation
Aortic Stenosis
06/24
11/34
JOURNEY, NCT06455787: J-Valve Transfemoral Pivotal Study

Not yet recruiting
N/A
171
NA
J-Valve Transfemoral (TF) System
JC Medical, Inc., Bright Research Partners, Minneapolis Heart Institute Foundation, Cardiovascular Research Foundation, New York
Aortic Valve Regurgitation, Aortic Valve Disease Mixed
07/26
07/30
NCT05966662: Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

Recruiting
N/A
145
US
IVL with Shockwave C2+ 2Hz Coronary IVL Catheter
Shockwave Medical, Inc.
Coronary Artery Disease, Myocardial Infarction
12/24
11/25
CLASP II TR, NCT04097145: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Recruiting
N/A
870
Canada, US
Edwards PASCAL System, Transcatheter tricuspid valve repair (TTVr), Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
12/24
03/29
NCT04198870: MitraClip REPAIR MR Study

Recruiting
N/A
500
Europe, Canada, US
MitraClipâ„¢ device implantation, Mitral Valve Repair Surgery
Abbott Medical Devices
Mitral Valve Regurgitation
04/26
04/34
ENVISION, NCT05932615: IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

Recruiting
N/A
1500
US
Navitor Transcatheter Aortic Valve Implantation (TAVI) System, Any Commercially Available Transcatheter Aortic Valve (CAV) System
Abbott Medical Devices
Aortic Valve Stenosis, Heart Valve Diseases, Aortic Valve Disease, Heart Disease Structural Disorder
04/27
04/36
Sibley, Shalamar D
NURA-009-21S, NCT05225233: tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity

Recruiting
N/A
124
US
Sham Transcranial Direct Current Stimulation (tDCS), Active Transcranial Direct Current Stimulation (tDCS)
VA Office of Research and Development
Obesity
03/26
04/26
Kehle-Forbes, Shannon M
COMPASS, NCT04581434: Psychotherapy for PTSD Among Veterans Also Receiving Drug or Alcohol Treatment

Completed
N/A
426
US
Prolonged Exposure Therapy, Cognitive Processing Therapy, Present Centered Therapy
Center for Veterans Research and Education, Patient-Centered Outcomes Research Institute, Minneapolis Veterans Affairs Medical Center
Stress Disorders, Post-Traumatic, Substance Use Disorders
04/24
04/24
CF-CPT, NCT04407767: A Case Formulation Approach to Cognitive Processing Therapy

Recruiting
N/A
256
US
Case Formulation plus Cognitive Processing Therapy, Cognitive Processing Therapy
VA Office of Research and Development
Posttraumatic Stress Disorder
09/24
08/25
PREVAIL, NCT06296186: Massed Prolonged Exposure for PTSD in Substance Use Treatment

Not yet recruiting
N/A
200
US
Prolonged Exposure Therapy
Veterans Medical Research Foundation, University of Minnesota, Center for Veterans Research and Education
Stress Disorders, Post-Traumatic, Substance Use Disorders
07/27
08/27
PORT, NCT06296589: Trauma-Informed Guilt Reduction Therapy Compared to Prolonged Exposure

Not yet recruiting
N/A
158
US
Trauma Informed Guilt Reduction Therapy, Prolonged Exposure Therapy
Veterans Medical Research Foundation, University of Minnesota, Center for Veterans Research and Education
Stress Disorders, Post-Traumatic
07/27
08/27
EMPOWER, NCT05797441: Testing the Effectiveness of a Therapist-Assisted Self-Management Program for Veterans Who Finished PTSD Therapy

Enrolling by invitation
N/A
90
US
EMPOWER, Treatment As Usual
VA Office of Research and Development
PTSD, Post Traumatic Stress Disorder
03/26
03/26
Sembrano, Jonathan
NCT04054401: SynerFuse Spinal Fusion and Neuromodulation Proof of Concept Study

Recruiting
N/A
20
US
DRG Neurostimulation with Spinal Fusion
SynerFuse, Inc
Spinal Fusion, Radiculopathy Lumbar, Chronic Pain
10/24
10/24
Meis, Laura A
NCT05491538: Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness

Recruiting
N/A
20
US
Social Cognition and Interaction Training-Work Edition (SCIT-WE)
VA Office of Research and Development
Schizophrenia, Bipolar Disorder, Depressive Disorder, Major, Stress Disorder, Post-Traumatic
11/24
11/24
NCT05974631: Evaluating Treatments for Suicidal Veterans With PTSD

Not yet recruiting
N/A
200
US
Dialectical Behavior Therapy, DBT, Dialectical Behavior Therapy Prolonged Exposure protocol, DBT PE, Prolonged Exposure therapy, PE, Suicide risk management, SRM
VA Office of Research and Development
Self-directed Violence, Post-traumatic Stress Disorder (PTSD)
04/27
07/27
Nixon, Joshua P
NCT04309864: CMAP Refinement for Pressure Injury Prevention

Recruiting
N/A
46
US
Use of CMAP app for education (in-hospital), Use of CMAP app (in-home)
VA Office of Research and Development
Pressure Ulcer
03/25
03/25
MEASURE-BD, NCT06204705: mHealth Estimate-based Algorithms Signaling Upcoming Recurrence of Episodes in Bipolar Disorders

Not yet recruiting
N/A
216
US
VA Office of Research and Development, National Center for PTSD, University of Wisconsin, Madison
Bipolar Disorder
09/27
09/27
MMSW-SCI, NCT04668326: Mobile Manual Standing Wheelchair for SCI

Recruiting
N/A
48
US
Manual Standing Wheelchair, Levo Summit Wheelchair, Mobile Manual Standing Wheelchair, Modified Levo Summit Wheelchair
VA Office of Research and Development
Spinal Cord Injuries
06/25
08/25
NCT05601869: Impact of Improving Footwear Options

Recruiting
N/A
18
US
UNYQ Prosthetic Ankle-Feet System, UNYQ Foot
VA Office of Research and Development, University of Minnesota
Amputation
10/25
12/25
NCT05776030: Multi-speed Ergonomic Wheelchair

Not yet recruiting
N/A
30
US
Single Speed Ergonomic Wheelchair, Multi-Speed Ergonomic Wheelchair
VA Office of Research and Development
Spinal Cord Diseases, Spinal Cord Injuries
10/25
12/25
NCT05884411: Evaluation of Left Bundle Branch Area Pacing As A Rescue Strategy for Cardiac Resynchronization Therapy Non-Response

Recruiting
N/A
24
US
Left bundle branch area pacing, LBBAP, Cardiac MRI, CMR
VA Office of Research and Development
Systolic Heart Failure, Heart Failure With Reduced Ejection Fraction, CRT Non-Response, Left Bundle Branch Area Pacing
03/28
03/28
Wetherbee, Erin
VALOR, NCT02984761: Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Recruiting
N/A
670
US
Stereotactic Radiotherapy, Stereotactic Body Radiation Therapy (SBRT) or Stereotactic Ablative Radiotherapy (SAbR), Anatomic Pulmonary Resection, Lobectomy or Anatomic Segmentectomy
VA Office of Research and Development
Lung Neoplasm
09/26
09/27
Wendt, Christine
NCT04169529: Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD)

Completed
N/A
42
US
Reveal LINQ
Medtronic Cardiac Rhythm and Heart Failure
Chronic Obstructive Pulmonary Disease (COPD)
06/23
06/23
Westermeyer, Joseph
NAP, NCT03668041: National Adaptive Trial for PTSD Related Insomnia

Recruiting
3
774
US
Trazodone, Eszopiclone, Placebo
VA Office of Research and Development
Insomnia
02/26
02/26
Michalets, James
VAST-D II, NCT05554627: VA Aripiprazole vs Esketamine for Treatment Resistant Depression

Withdrawn
4
940
US
Esketamine, Spravato (for depression), Ketanest (for anesthesia), Aripiprazole, Abilify, Aristada
VA Office of Research and Development
Depressive Disorder, Major
10/23
10/23
NAP, NCT03668041: National Adaptive Trial for PTSD Related Insomnia

Recruiting
3
774
US
Trazodone, Eszopiclone, Placebo
VA Office of Research and Development
Insomnia
02/26
02/26
SCEPTER, NCT04142177 / 2013-003001-26: Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response

Recruiting
N/A
2529
US
Pain EASE, Tailored exercise, Continued Care and Active Monitoring, Cognitive Behavioral Therapy (CBT), Spinal Manipulation Therapy (SMT), Yoga
VA Office of Research and Development
Chronic Low Back Pain
06/25
06/26
Klein, Mark
NCT04939090: Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

Recruiting
3
360
US
Olanzapine, Megestrol Acetate, Questionnaire Administration
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Advanced Malignant Solid Neoplasm, Anorexia, Hematopoietic and Lymphoid Cell Neoplasm
05/26
12/26
CASPAR, NCT04455750: A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

Active, not recruiting
3
61
US
Enzalutamide, Rucaparib camsylate, Placebo, Leuprolide Acetate, Goserelin Acetate, Degarelix, Quality-of-Life Assessment, Questionnaire Administration
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
05/24
09/26
PDIGREE, NCT03793166: Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The Study

Checkmark Initiated in combination with nivolumab and ipilimumab for 1L RCC
Jan 2019 - Jan 2019: Initiated in combination with nivolumab and ipilimumab for 1L RCC
Active, not recruiting
3
1175
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Cabozantinib, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Ipilimumab, Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody, BMS-734016, Ipilimumab Biosimilar CS1002, MDX-010, MDX-CTLA4, Yervoy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Nivolumab, ABP 206, BCD-263, BMS-936558, CMAB819, MDX-1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO-4538, Opdivo, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
National Cancer Institute (NCI)
Clear Cell Renal Cell Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes, Metastatic Malignant Neoplasm in the Soft Tissues, Metastatic Malignant Neoplasm in the Viscera, Sarcomatoid Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8
09/24
09/24
ACCIO, NCT04267848: Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial

Recruiting
3
1210
US, RoW
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Gemcitabine Hydrochloride, dFdCyd, Difluorodeoxycytidine Hydrochloride, Gemcitabine HCI, Gemzar, LY-188011, LY188011, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Observation, Inspection, Visual Inspection, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Pembrolizumab, BCD-201, GME 751, GME751, Keytruda, Lambrolizumab, MK-3475, Pembrolizumab Biosimilar BCD-201, Pembrolizumab Biosimilar GME751, Pembrolizumab Biosimilar QL2107, QL2107, SCH 900475, Pemetrexed Disodium, Alimta, Almita, LY231514, N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Disodium Salt, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8
12/24
12/24
NCT03811015: Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

Recruiting
3
636
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Fludeoxyglucose F-18, 18FDG, FDG, Fludeoxyglucose (18F), fludeoxyglucose F 18, Fludeoxyglucose F18, Fluorine-18 2-Fluoro-2-deoxy-D-Glucose, Fluorodeoxyglucose F18, Intensity-Modulated Radiation Therapy, IMRT, Intensity modulated radiation therapy (procedure), Intensity Modulated RT, Intensity-Modulated Radiotherapy, Radiation, Intensity-Modulated Radiotherapy, Nivolumab, ABP 206, BCD-263, BMS-936558, CMAB819, MDX-1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO-4538, Opdivo, Patient Observation, Active Surveillance, deferred therapy, expectant management, Observation, Watchful Waiting, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT
National Cancer Institute (NCI)
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
01/27
01/27
EVOLVE CLL/SLL, NCT04269902: Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), Study

Recruiting
3
247
Canada, US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Obinutuzumab, Anti-CD20 Monoclonal Antibody R7159, GA-101, GA101, Gazyva, huMAB(CD20), R7159, RO 5072759, RO-5072759, RO5072759, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Venetoclax, ABT-0199, ABT-199, ABT199, GDC-0199, RG7601, Venclexta, Venclyxto
National Cancer Institute (NCI)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
10/28
10/28
EA5163, NCT03793179: Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

Active, not recruiting
3
600
Canada, US, RoW
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Pembrolizumab, BCD-201, GME 751, GME751, Keytruda, Lambrolizumab, MK-3475, Pembrolizumab Biosimilar BCD-201, Pembrolizumab Biosimilar GME751, Pembrolizumab Biosimilar QL2107, QL2107, SCH 900475, Pemetrexed, MTA, Multitargeted Antifolate, Pemfexy, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT
National Cancer Institute (NCI)
Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8
12/28
12/28
ALCHEMIST, NCT02201992: Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An Treatment Trial)

Recruiting
3
168
US, RoW
Clinical Observation, Crizotinib, MET tyrosine kinase inhibitor PF-02341066, PF-02341066, PF-2341066, Xalkori, Laboratory Biomarker Analysis
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7
05/36
05/36
NCT04137107: Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Recruiting
2/3
348
US, RoW
Oxaliplatin, Duloxetine Hydrochloride, Duloxetine, Quality-of-Life Assessment, Questionnaire Administration, Placebo
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8
02/25
12/25
VA STARPORT, NCT04787744: Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Recruiting
2/3
464
US
PET-directed Local Therapy using Surgery, PET-directed Local Therapy using Radiation, Salvage Local Therapy for locally recurrent disease, Goserelin, Histrelin, Leuprolide & Triptorelin, ADT + Nilutamide, Flutamide, & Bicalutamide, Degarelix & Relugolix, ADT + Docetaxel +/- prednisone, ADT + Abiraterone + Prednisone, ADT + Abiraterone + Methylprednisolone, ADT + Apalutamide, ADT + Enzalutamide, Prostate-directed Radiation for De novo oligometastatic prostate cancer
VA Office of Research and Development
Prostate Cancer, Oligometastasis, Oligorecurrence, Recurrent Prostate Cancer, Metastatic Prostate Cancer, De Novo Prostate Cancer
07/25
12/25
Lung-MAP Non-Match Sub-Study, NCT05096663: Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Checkmark Initiation of Lung-MAP trial in combination with Keytruda for 2L NSCLC
Apr 2022 - Apr 2022: Initiation of Lung-MAP trial in combination with Keytruda for 2L NSCLC
Active, not recruiting
2/3
82
US
Cobalamin, B12 Vitamin, Cobalamin (1+), VIT B12, Vitamin B-12, Vitamin B12, Vitamin-B12, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycadron, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decadron DP, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasone Intensol, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Dxevo, Fluorodelta, Fortecortin, Gammacorten, Hemady, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex, Docetaxel, Docecad, RP56976, Taxotere, Taxotere Injection Concentrate, Folic Acid, 2-[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]aminopentanedioic acid, FA, Folacin, Pteroylmonoglutamic Acid, Vitamin B9, Vitamin Bc, Gemcitabine, dFdC, dFdCyd, Difluorodeoxycytidine, Nogapendekin Alfa, ALT 803, ALT-803, ALT803, Fusion Protein Consisting of IL-15N72D and IL-15RaSu/FC, IL-15N72D/IL-15Ra-Fc, IL-15N72D:IL-15RaSu/Fc Fusion Complex, N 803, N-803, N803, Superagonist Interleukin-15:Interleukin-15 Receptor AlphaSu/Fc Fusion Complex Alt-803, Pembrolizumab, Keytruda, Lambrolizumab, MK-3475, SCH 900475, Pemetrexed, MTA, Multitargeted Antifolate, Pemfexy, Ramucirumab, Anti-VEGFR-2 Fully Human Monoclonal Antibody IMC-1121B, Cyramza, IMC-1121B, LY3009806, Monoclonal Antibody HGS-ETR2
SWOG Cancer Research Network, National Cancer Institute (NCI)
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8
02/27
12/27
BRACeD, NCT04038502: Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Recruiting
2
100
US
Carboplatin, Paraplatin, Olaparib, Lynparza
VA Office of Research and Development
Metastatic Castrate Resistant Prostate Cancer, BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, RAD51B, RAD51C, RAD51D, or RAD54L Mutations
08/24
08/25
Lung-MAP Sub-Study, NCT05364645: Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer

Recruiting
2
74
US
Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Pemetrexed, MTA, Multitargeted Antifolate, Pemfexy, Selpercatinib, LOXO-292, RET Kinase Inhibitor LOXO-292, Retevmo, WHO 10967
SWOG Cancer Research Network, National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8
06/23
05/29
 

Download Options